Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
Jim and Marilyn Islam Fund for Pediatric Cancer Research will support rising star professorship…
Imagine if when a soon-to-be mother arrived at a hospital in labor, her health care team could predetermine what challenges she might encounter with breastfeeding and develop a game plan to address any lactation complications, before she even gave birth.
An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to “wake up” the immune system against cancer.
Continuing UF College of Medicine’s revolutionary work developing the adeno-associated virus (AAV) vector, Dr. Barry Byrne, M.D., Ph.D., Associate Chair of Pediatrics and Director of the Powell Gene Therapy Center, will serve as President of the American Society of Gene and Cell Therapy (ASGCT) during the society’s 30th…
John Ligon, M.D., an assistant professor in the Department of Pediatrics, is leading the trial that is investigating the safety and immune system response from RNA-LP in children with recurrent high-grade glioma, a brain tumor, and recurrent osteosarcoma, a bone cancer.
Years of Service Celebration The following employees were recognized for their dedication and commitment to the department. Image Gallery Josef Neu – 40 years Daniel Driscoll – 35 years Lainey Bertisch – 30 years Sharon Hennessey – 30 years Michael Matheny – 30 years Sergei Zolotukhin – 30 years…
Awards & Honors US News & World Report Rankings 5 specialties at UF Health Shands Children’s Hospital ranked among the best in the nation in the latest U.S. News & World Report survey!Ranked specialties are Pulmonology and Lung Surgery (No. 23), Diabetes and Endocrinology (No. 33), Cardiology and Heart…
A tele-education program for health care providers who treat people with diabetes resulted in significant improvements in patient outcomes, including better blood sugar levels and increased use of medical devices to manage the disease, a University of Florida study finds.
The understanding of Type 1 diabetes races forward, propelled by Big Data, technological advances, and the urgent hopes of millions globally who long for new treatments or an elusive cure.
